Anthracycline and anthraquinone anticancer agents: Current status and recent developments

Pharmacology and Therapeutics

Volumn 60, Issue 2, 1993, Pages 185-214

  William Lown, J ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Anthracyclines; cardiotoxicity; daunorubicin; doxorubicin; helicases; topoisomerases

Indexed keywords

ANTHRACYCLINE DERIVATIVE; ANTHRAQUINONE DERIVATIVE; ANTINEOPLASTIC AGENT; DAUNORUBICIN; DOXORUBICIN;

BIOSYNTHESIS; CARDIOTOXICITY; CONFERENCE PAPER; DRUG DEVELOPMENT; DRUG MECHANISM; DRUG STRUCTURE; PRIORITY JOURNAL;

AMINO SUGARS; ANIMAL; ANTHRAQUINONES; ANTIBIOTICS, ANTHRACYCLINE; ANTINEOPLASTIC AGENTS; CHEMISTRY, ORGANIC; DNA HELICASES; DNA TOPOISOMERASES, TYPE I; DRUG INTERACTIONS; HUMAN; STEREOISOMERISM; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0027817393     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/0163-7258(93)90006-Y     Document Type: Review

References (112)

1. N-Alkylation of anthracyclines
2. Morpholinyl anthracyclines
3. Synthesis of new doxorubicin analogs
4. Daunomycin I the structure of daunomycin
5. Conversion of daunomycin to adriamycin
6. Adriamycin, 14-hydroxydaunomycin, a new antitumor antibiotic from S. peucetius var. caesius
7. Adriamycin (14-hydroxydaunomycin) a novel antitumor antibiotic
8. Synthesis and biological evaluation of some 14-O-acyl derivatives of adriamycin
9. Adriamycin (NSC-123127): new chemical developments and analogs
10. Synthesis and antitumor activity of 4-demethoxydaunorubicin, 4-demethoxy-7,9-diepidaunorubicin and their β-anomers
11. Microbial reduction of the side-chain carbonyl of daunorubicin and N-acetyldaunorubicin
12. Daunorubicinol, a major metabolite of daunorubicin: isolation from human urine and enzymatic reactions
13. Daunorubicin metabolism by rat tissue preparations
14. Helicase inhibition by anthracycline anticancer agents
15. Iron(III) adriamycin and iron(III)-daunorubicin complexes. Physicochemical characteristics, interaction with DNA and antitumor activity
16. Cardiac toxicity of daunomycin
17. Structure of aglycone of carminomycin, an antitumor antibiotic
18. Anthracyclinone und anthracycline
19. Anthracyclinone und anthracyclines
20. Rhodomycin, ein rotes antibioticum aus actinomyceten
21. Uber atinomycetenforbstaffe VI Pyrromycinone
22. Rhodomycinone und isorhodomycinone rhodomycin IV Antibiotica aus actinomyceten III
23. Rhodinose, eine tridesoxy hexose
24. Rhodomycine VII antibiotica aus actinomycetin XLIX β-Rhodomycinone und γ-rhodomycinon
25. Rhodosamine-isolation constitution and configuration
26. 14C
27. Daunomycin: a new antibiotic with antitumor activity
28. Adriamycin (NSC-123,127): a new antibiotic with antitumor activity
29. Daunomycin (daunorubicin) and adriamycin and structural analogs: biological activity and mechanism of action
30. Un novel antibiotique a proprietes cytostatiques: la rubidomycine
31. Molecular pharmacology of anthracyclines: demonstration of multiple mechanistic classes of anthracyclines
32. Stoffwechselprodukte von actinomyceten XVI cinerubine
33. A new anthracycline metabolite D788-1 (10-carboxy-13-deoxocarminomycin) in daunorubicin beer
34. Selective tumor localization and improved therapeutic index of anthracyclines encapsulated in long-circulating liposomes
35. Metal anthracyclines and anthracenedione complexes, a new class of anticancer agents
36. Cinchonine, a potent efflux inhibitor to circumvent anthracycline resistance in vivo
37. 4-Demethoxy-9-deoxy-9-methyldaunorubicin
38. A differential interaction of daunomycin adriamycin and their derivatives with human erythrocytes and phospholipid bilayers
39. Quelamycin, a new derivative of adriamycin with several possible therapeutic advantages
40. Clinical pharmacokinetics of the anthrapyrazole CI-941: factors comprising the implementation of a pharmacikinetically guided doese escaliation scheme
41. Descrizione e classificazione di un attionamicette (Streptomyces peucetius sp. nova) produltore di una sostanza ad attivite antitumorale: la daunomicina
42. Microbial N-acetylation of daunorubicin and daunorubicinol
43. Selective dealkylation of activated aromatic ethers
44. A preparative synthesis of 3-amino-2,3,6-tri-deoxy-l-lyxo-hexose(daunosamine)hydrochloride from d-mannose
45. Daunorubicin metabolism in acute nonlymphocytic leukemia
46. Akrobomycin, a new anthracycline antibiotic
47. N-Tri-fluoro-acetyl-adriamycin-14-valerate, an analog with greater experimental antitumor activity and less toxicity than adriamycin
48. Metabolic products of micro-organisms LXXXVI Structure of cinerubin A
49. Structures of steffimycin and steffimycin B1
50. Recent aspects of anthracyclinone chemistry
51. Structure of daunomycin X-ray analysis of N-bromo-acetyl-daunomycin solvate
52. The structure of aklavin
53. Molecular mechanisms of action of anticancer agents involving free radical intermediates
54. 10-Acetyl-10-hydroxyxantho[2,3-f]tetralin-8-glycosides as angular chromophore analogs of anthracyclines: synthesis, redox properties, microsomal oxygen consumption and antileukemic evaluation
55. The synthesis of daunosamine
56. Microbial metabolism of anthracycline antibiotics
57. Biotransformation of anthracycline antibiotics
58. Bacterial metabolism of daunomycin
59. Pharmacology and phase I/II clinical trials
60. Drugs for neoplastic diseases
61. A new anthracycline antibiotic N-formyl-13-dihydrocarminomycin
62. 4-O-(β-d-Glycopyranosyl)-ϵ-rhodomycinone: a new microbial transformation product of rhodomycinone
63. The structure of a new anthracycline, cinerubin X produced by a blocked mutant of Streptomyces violaceeo-chromogenes
64. New antitumor antibiotics: musettamycin and marcellomycin from bohemic acid complex
65. Microbial transformations of anthracycline antibiotics and development of new anthracyclines
66. Recent developments in the process improvement of production of antitumor arthracycline antibiotics
67. Antitumor anthracycline antibiotics from microbial origins
68. New antitumor antibiotics, aclacinomycins A
69. Biosynthesis of anthracycline antibiotics by Streptomyces galilaeus
70. Microbial conversion of daunomycin carcinomycin I and feudomycin A to adriamycin
71. Recent developments in the chemistry of natural phenolic compounds
72. Incorporation of propionate in the biosynthesis of ϵ-pyrromycinone (rutilantinone)
73. Anticancer 4-demethoxyanthracyclines
74. 2Na
75. Stereochemical requirements in the antitumor anthracyclines
76. Synthesis of 10-methoxy-daunorubicins and of 10(R)-methoxy-oxorubicin via opening of an oxirane intermediate
77. Stereospecific epoxidation of anthracyclinones: a route to 8(R)-methoxy-daunomycinone
78. DNA topoisomerase II as an intracellular target in anthracycline treatment of cancer
79. The synthesis of d-daunosamine N-benzoate
80. Die struktur des cinerubin B
81. Stoffwechselprodukte von mikroorganismen 104. Die struktur des cinerubins B
82. Design, biochemical pharmacology, electrochemistry and tumor biology of antitumor anthrapyrzoles
83. A manual on quantitative drug evaluation on experimental tumor systems
84. Damage to the intrinsic cardiac neurons by ribidomycin (daunorubicin)
85. In vitro evidence for direct complexation of ADR-529/ICRF-187 [(+-1,2-bis-(3,5-dioxopiperazin-1-yl)propane] onto an existing feric-anthracycline complex
86. New adriamycin (A) and daunorubicin (D) metabolites in human urine
87. Adriamycin metabolism in man. Evidence from urinary metabolites
88. New anthracyclinone metabolites from two blocked mutants of Streptomyces galilaeus MA144-M1
89. 5-Imino-daunorubicin reduced cardiotoxic properties in an antitumor anthracycline
90. Biogenesis of linear tri- and tetracyclic oligopeptides and their glycosides
91. Anthracyclines
92. Microbial transformations of alkanoic acid, a potential early intermediate in the biosynthesis of anthracyclies
93. Isolation, characterization and degradation of nogalamycin
94. The structure of nogalamycin
95. Structure-activity relationship of daunorubicin and its peptide derivatives
96. Synthetic studies of hydro-naphthacene antibiotics I The synthesis of 4-demethoxy-7-O-methyl caunomycinone
97. Synthetic studies of hydronaphthacenic antibiotics II Total synthesis of daunomycinone
98. Antitumor activity of some derivatives of daunorubicin at the amino and methyl ketone functions
99. Intensely potent anthracycline antibiotic oxaunomycin produced by a blocked mutant of the daunorubicin-producing micro-organism